New Approach to Pancreatic Cancer Screening May Help Catch Disease Earlier

A team led by Van Andel Research Institute (VARI) scientists has developed a new, simple blood test that, when combined with an existing test, detects nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate.

New approach to pancreatic cancer screening. Image credit: Tannim101/Wikipedia (CC BY 3.0)

Pancreatic cancer is difficult to diagnose because it often doesn't have obvious early symptoms. By the time the disease is found, it typically is quite advanced, complicating treatment and leading to poorer outcomes. Only 8.5 percent of people with pancreatic cancer survive past five years.

Both tests detect and measure levels of sugars produced by pancreatic cancer cells that subsequently escape into the blood stream. The sugar measured by the new test—sTRA—is produced by a different subset of pancreatic cancers than CA-19-9, the sugar measured by the existing test.

When used together, the tests cast a broader net and detect subtypes of pancreatic cancer that may have been missed by using one of the two tests on its own.

The CA-19-9 test was developed almost 40 years ago and detects only about 40 percent of pancreatic cancers. It currently is used to confirm diagnosis of pancreatic cancer or track disease progression rather than screen for the disease.

The improved detection rate offered by the combined use of the sTRA and CA-19-9 tests makes this approach a viable option for screening and early intervention, particularly in people who have a higher risk for developing the disease.

This includes people who have a family history of pancreatic cancer, who have had pancreatic cysts or chronic pancreatitis, or who were diagnosed with type 2 diabetes later in life.

Emerging evidence has suggested that sudden onset of diabetes after age 50 could be an early symptom of some pancreatic cancers. Currently, life-long diabetes is not considered to be a risk factor for or indicator of pancreatic cancer. (Tasnim News Agency)

YOU MAY ALSO LIKE

Multiple Sclerosis Treatment Developed in Australia Shows Promise

Australian researchers have made a breakthrough in the treatment of Multiple Sclerosis using immunotherapy. Their world-first trial has produced promising results for the majority of patients enrolled, they said, including a reduction in fatigue and improvements in mobility and vision.

Oxygen can impair cancer immunotherapy in mice

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers.

Cambridge scientists reverse ageing process in rat brain stem cells

New research reveals how increasing brain stiffness as we age causes brain stem cell dysfunction, and demonstrates new ways to reverse older stem cells to a younger, healthier state.

Tell-tale biomarker detects early breast cancer

Researchers have shown that magnetic resonance imaging can detect the earliest signs of breast cancer recurrence and fast-growing tumors. Their approach detects micrometastases, breakaway tumor cells with the potential to develop into dangerous secondary breast cancer tumors elsewhere in the body. The approach may offer an improved way to detect early recurrence of breast cancer in women and men.

Study finds link between long-term exposure to air pollution and emphysema

Long-term exposure to air pollution was linked to increases in emphysema between 2000 and 2018, according to a new study.

Tumor DNA in Blood Reveals Lymphoma Progression

Using an advanced genetic test, researchers were able to detect diffuse large B-cell lymphoma (DLBCL) in blood serum before it could be seen on CT scans.